Hidden in plain sight: Well-known drug could yield new treatment for herpes viruses

March 14, 2016
Sankar Swaminathan, M.D., professor of internal medicine and chief of infectious diseases, and Dinesh Verma, Ph.D., research assistant professor of internal medicine, University of Utah School of Medicine. Credit: University of Utah Health Sciences

Today, there is only one class of antiviral medicines against herpesviruses—a family of viruses that cause mononucleosis, herpes, and shingles, among other illnesses - meaning options for treating these infections are limited. If viruses become resistant to these frontline treatments, a growing problem particularly in clinical settings, there are no alternative drugs to serve as backup.

In a search for new drugs to treat , scientists from the University of Utah School of Medicine found that a medicine routinely used to treat heart failure, spironolactone, has an unexpected ability to block infection by Epstein Barr virus (EBV), a herpesvirus that causes mono and is associated with several human cancers. They find that the 's antiviral properties stem from its ability to block a key step in viral infection that is common to all herpesviruses. Spironolactone's target is distinct from that of existing drugs, revealing that it could be developed into a new class of anti-herpesvirus drug.

"It's remarkable that a drug we have used safely in the clinic for over 50 years is also an effective EBV inhibitor," says senior author Sankar Swaminathan, M.D., chief of infections disease at University of Utah Health Care and professor of internal medicine. "It goes to show how basic research can reveal things we would never have found otherwise." In collaboration with research assistant professor of internal medicine Dinesh Virma, Ph.D., and Jacob Thompson, he published the study in the Proceedings of the National Academy of Sciences.

Swaminathan's team uncovered spironolactone's antiviral properties in a screen to identify drugs that work through a mechanism that is different from that of existing anti-herpesvirus drugs. Currently available drugs block a middle step of the viral infection cycle by inhibiting virus' ability to replicate DNA. They found that like these drugs, spironolactone can block EBV replication in cells, but it does so by targeting the so-called SM protein, required for a late step in the infection cycle.

Importantly, spironolactone's ability to block viral infection appears to be independent from its ability to treat heart failure. Previous studies showed that the drug treats heart failure through a different, metabolic mechanism. This study demonstrates that a drug similar to spironolactone shares its ability to treat but not its antiviral properties. Together the results suggest the two mechanisms are separable.

"We think there is great potential to modify this molecule so that it can work as an antiviral without having undesired side effects," explains Swaminathan. Spironolactone could be developed as a new medicine against EBV, a common and dangerous infection among transplant and other immunocompromised patients.

But because all herpesviruses depend on SM-like proteins to spread infection, the work also has broader implications. Spironolactone could be a template for a new class of drug directed against all herpesviruses.

"We have found a new therapeutic target for herpesviruses," says Swaminathan. "We think it can be developed it into a new class of to help overcome the problem of drug resistant infections."

Explore further: Study shows that certain herpes viruses can infect human neurons

More information: Spironolactone blocks Epstein–Barr virus production by inhibiting EBV SM protein function, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1523686113

Related Stories

Study shows that certain herpes viruses can infect human neurons

December 4, 2015
For years, researchers have noted a tantalizing link between some neurologic conditions and certain species of the herpes virus. In patients with Alzheimer's disease, multiple sclerosis, and cerebellar ataxia, among other ...

Biologists develop novel antiviral approach to dengue fever

December 2, 2015
The virus that causes dengue fever infects an estimated 390 million people per year. Infection often leads to symptoms so severe that it was once called "breakbone fever" for the pain it causes, or even death. It's the fastest-growing ...

Cell culture experiments reveal potent antiviral activity of Cistus incanus extracts against HIV and Ebola

February 2, 2016
Scientists at the Helmholtz Zentrum München discover that extracts of the medicinal plant Cistus incanus (Ci) prevent human immunodeficiency viruses from infecting cells. Active antiviral ingredients in the extracts inhibit ...

Thwarting herpes, scientists open antiviral drug path

September 5, 2013
While herpesviruses infect most animals – including humans – with incurable disease, Cornell researchers have found a genetic trail to thwart its reproductive powers, cutting its infective powers by a factor of up to ...

Scientists describe new herpes treatment strategy

December 3, 2014
Scientists have developed a novel treatment approach for persistent viral infections such as herpes.

Spironolactone seems effective for female pattern hair loss

September 26, 2015
(HealthDay)—Spironolactone may be an effective treatment for female pattern hair loss (FPHL), especially among patients with signs of hyperandrogenism, according to a study published in the October issue of the Journal ...

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

SciTechdude
5 / 5 (1) Mar 14, 2016
Considering this (Herpes Virus) was recently linked to Alzheimer's as a probable contributing factor, a potential cure couldn't be more timely!
vitaliy
not rated yet Mar 24, 2016
I hope that this will really help people not just another hope that leads to nowhere.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.